Block the final stage of gastric acid production, suppress gastric acid due to all sources; Inhibit growth of H. pylori; Prodrug that is activated by acid in the canaliculus then it attaches irreversibly to the proton pump
Forms viscous gel at low pH; protects gastric luminal surface from degradation by acid & pepsin
AE: Constipation
15
New cards
Colloidal Bismuth
Stimulates secretion of bicarbonate & prostaglandin; inhibits growth of H. pylori & forms barrier to protect from ulcers
16
New cards
Diarrhea
17
New cards
Opioid Agonists
Diphenoxylate, Loperamide
Diarrhea, Traveler’s Diarrhea
18
New cards
OA MoA
Inhibit GI motility, decrease secretion & absorption secondary to stimulating the inhibitor opioid receptors, allowing for water/nutrients & electrolytes to be absorbed
Severe or non-severe Gram + Cocci infection (S. aureus)
84
New cards
Macrolide Antibiotic
Fidaxomicin, Azithromycin
Severe or non-severe C. difficile infection
Non-systemic, minimally absorbed into the bloodstream; Bactericidal effects
Traveler's Diarrhea (areas where Campylobacter is highly endemic)
85
New cards
Salicylate
Bismuth Subsalicylate
Traveler’s Diarrhea
86
New cards
Antibiotic
Quinolones (Antibiotic)
Norfloxacin
Levofloxacin, Ciprofloxacin
start on first day in country until 1-2 days after return
Second line: Rifaximin
Traveler’s Diarrhea
87
New cards
Antimotility Agent
Loperamide
Traveler’s Diarrhea
CI: Bloody Stool and/or fever
88
New cards
Giardiasis
Tinidazole, Nitazoxanide
Metronidazole (not FDA app. for Gia.)
89
New cards
Inflammatory Bowel Disease
90
New cards
Aminoglycoside Azo Compounds
Sulfasalazine, Balsalazide, Olsalazine
91
New cards
Amino Azo MoA
Ulcerative Colitis
Not absorbed, but delivered to the colon; Prodrugs that must be converted into the active formÂ
AE Sulfas.: Folate deficiency, nausea, vomiting, diarrhea, headaches and arthralgia
92
New cards
Aminoglycoside Mesalamine Compounds
Pentasa, Asacol, AprisoLialda
93
New cards
Amino Mesalamine MoA
Ulcerative Colitis
5-ASA inhibits inflammation; inhibits COX enzymes to reduce prostaglandin synthesis; inhibits activity of NF-kB
94
New cards
Corticosteroid
Prednisone, Hydrocortisone(Short-term course induction of IBD remission), Methyprednisolone, Prednisolone, Budesonide(Induction in mild to moderate Crohn's disease)
95
New cards
Corticosteroid MoA
Suppression of inflammation & immune system; inhibit NF-kB and phospholipase A2
AE: Osteoporosis, bone loss, fractures, hyperglycemia, hypervolemia, hypertension, increased vulnerability to infections, weight gain, thinning of skin, easy bruising, poor wound healing, may exacerbate GI bleeding
96
New cards
Immunosuppressants
6-Mercaptopurine, Azathioprine
6-Mer: Prodrug, metabolized by a non-enzymatic reaction to form 6 - Mercaptopurine
Aza: Inhibits purine biosynthesis
AE: Bone marrow depression & hepatotoxicity
97
New cards
Anti-metabolite
Methotrexate IM
Steroid Sparing & Maintenance of Crohn's Disease remission
MoA: Anti-inflammatory; interferes with action of IL-1, stimulates adenosine release to inhibit T cell activation & stimulates apoptosis of activated T lymphocytes
98
New cards
Anti-TNF Antibodies
Infliximab, Adalimumab, Certolizumab, Golimumab
99
New cards
Infliximab MoA IV
Chimeric monoclonal antibody with both murine (mice) & human amino acid sequences
Induction & Maintenance of remission in Ulcerative Colitis
AE: Flu-like infusion reaction may worsen congestive heart failure